Evidence map›Paper›PMID 37992021›Full record

ArticlePLOS digital health2023

A software package for efficient patient trajectory analysis applied to analyzing bladder cancer development.

Charlotte Herzeel, Ellie D'Hondt, Valerie Vandeweerd, Wouter Botermans, Murat Akand, Frank Van der Aa, Roel Wuyts, Wilfried Verachtert

Abstract read
In one paragraph

Article in PLOS digital health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Evaluation of trajectory analysis for disease risk assessment: a scoping review.Journal of the American Medical Informatics Association : JAMIA · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Charlotte HerzeelExaScience Lab, imec, Leuven, Belgium.ORCID https://orcid.org/0000-0002-9319-9885
Ellie D'HondtExaScience Lab, imec, Leuven, Belgium.
Valerie VandeweerdJanssen Research & Development, a division of Janssen Pharmaceutica NV, Beerse, Belgium.
Wouter BotermansJanssen Research & Development, a division of Janssen Pharmaceutica NV, Beerse, Belgium.
Murat AkandDepartment of Urology, University Hospitals Leuven, Leuven, Belgium.
Frank Van der AaDepartment of Urology, University Hospitals Leuven, Leuven, Belgium.
Roel WuytsExaScience Lab, imec, Leuven, Belgium.
Wilfried VerachtertExaScience Lab, imec, Leuven, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present the Patient Trajectory Analysis Library (PTRA), a software package for explorative analysis of patient development. PTRA provides the tools for extracting statistically relevant trajectories from the medical event histories of a patient population. These trajectories can additionally be clustered for visual inspection and identifying key events in patient progression. The algorithms of PTRA are based on a statistical method developed previously by Jensen et al, but we contribute several modifications and extensions to enable the implementation of a practical tool. This includes a new clustering strategy, filter mechanisms for controlling analysis to specific cohorts and for controlling trajectory output, a parallel implementation that executes on a single server rather than a high-performance computing (HPC) cluster, etc. PTRA is furthermore open source and the code is organized as a framework so researchers can reuse it to analyze new data sets. We illustrate our tool by discussing trajectories extracted from the TriNetX Dataworks database for analyzing bladder cancer development. We show this experiment uncovers medically sound trajectories for bladder cancer.

Identifiers

PMID37992021
PMCPMC10664923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.